• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: THORATEC SWITZERLAND GMBH THORATEC CENTRIMAG 34F DRAINAGE CANNULA

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

THORATEC SWITZERLAND GMBH THORATEC CENTRIMAG 34F DRAINAGE CANNULA Back to Search Results
Catalog Number 201-50067
Device Problems Loss of or Failure to Bond (1068); Fracture (1260); Leak/Splash (1354)
Patient Problem Stroke/CVA (1770)
Event Date 07/19/2015
Event Type  Injury  
Manufacturer Narrative
(b)(4): approximate age of device - 37 days.Information regarding the manufacture date is pending.The patient remains on biventricular extracorporeal support with no further issues reported.No additional information was provided.A supplemental report will be submitted when the manufacturer¿s investigation is completed.
 
Event Description
It was reported that the patient was on biventricular extracorporeal circulatory support for approximately 37 days when the left ventricle drainage cannula began to leak.The patient had been ambulating when the drainage cannula reportedly cracked circumferentially at the distal connection and it appeared that the adhesive had come loose.The distal portion of the drainage cannula was spliced to a new extracorporeal blood pump circuit.The patient remains ongoing with biventricular support.It was reported that the patient experienced a stroke as a result of the disintegration.Unspecified treatment was rendered for the stroke.No specific information regarding the stroke or any symptoms was provided.
 
Manufacturer Narrative
The referenced user facility medwatch report is attached.The user facility report number was not provided.No further information was provided.A supplemental report will be submitted when the manufacturer¿s investigation is completed.
 
Event Description
Additional information was received from a user facility report on (b)(6) 2015 stating: (b)(6) year old male transferred from another facility with cardiogenic shock/respiratory failure on (b)(6) 2015 who was placed on va ecmo, then transitioned to bivad centri-mag with removal of ecmo/iabp on (b)(6).By (b)(6) his condition had improved and bivad explant was planned.At 10:22am rn responded immediately to call by patient's wife who had just removed the patient from the bedpan.The nurse noted a large amount of blood in the sheets and lvad inflow cannula that was disconnected; the tubing was immediately reconnected.Ct fellow at bedside clamped both rvad and lvad outflow.Maps dropped.Lij double central line was inserted and prbcs administered.Lvad team changed the dislodged cannula tubing with resumption of blood flow.Pt.Developed monoclinic movements and head ct was performed which showed hemorrhagic conversation of old pca infarct; likely representing diffuse hypoxic brain injury due to either hypotension or new air emboli.Examination of tubing after the event showed a crack.
 
Manufacturer Narrative
It was initially reported that the device was not returning for evaluation.The device was subsequently received.Device evaluation: the separation of the drainage cannula from the barbed connector was confirmed through a photograph that was provided by the hospital; however, a root cause for the event could not be conclusively determined through the evaluation.The barbed connector was returned attached to the venous tubing and was secured with a zip tie.The cannulae were not returned.Organic and elemental analysis of the barbed connector were conducted and residue from the pvc cannula was observed over a wide area of the barbed connector, indicating that solvent bonding between the barbed connector and the cannula had occurred.A review of the device history records revealed no deviations from manufacturing or quality assurance specifications.The instructions for use states that the cannula has not been qualified through in vitro, in vivo, or clinical studies for use greater than 6 hours.The patient and family information document lists stroke and major bleeding as potential complications that may be associated with the use of the centrimag system.The documentation also states that any of the complications listed may cause serious injury or death.The manufacturer is closing the file on this event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
THORATEC CENTRIMAG 34F DRAINAGE CANNULA
Type of Device
CANNULA
Manufacturer (Section D)
THORATEC SWITZERLAND GMBH
6035 stoneridge drive
zurich
SZ 
Manufacturer (Section G)
THORATEC CORPORATION
6035 stoneridge drive
technoparkstrasse 1
pleasanton CA 94588
Manufacturer Contact
robert fryc
23 fourth avenue
burlington, MA 01803
781272-013
MDR Report Key5023508
MDR Text Key23796763
Report Number2916596-2015-01536
Device Sequence Number1
Product Code DWF
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Health Professional
Type of Report Followup
Report Date 07/23/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date09/30/2016
Device Catalogue Number201-50067
Device Lot Number2014091051
Other Device ID NumberN/A
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer09/10/2015
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received08/21/2015
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received04/25/2016
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured09/30/2014
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age69 YR
Patient Weight69
-
-